Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

YouScript IMPACT (Improving Medication Protocols and Abating Cost of Treatment) Registry

NCT02191358 is registered in ClinicalTrials.gov with Genelex Corporation as lead sponsor.

NCT NCT02191358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02191358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
YouScript IMPACT (Improving Medication Protocols and Abating Cost of Treatment) Registry
Lead sponsor
Genelex Corporation
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
August 31, 2015
Enrollment
800 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug events, adverse drug reactions, cytochrome p450 cyp2c19 enzyme deficiency, cytochrome p450 cyp2c9 enzyme deficiency, cytochrome p450 cyp2d6 enzyme deficiency, cytochrome p450 cyp3a enzyme deficiency, cytochrome p450 enzyme deficiency, drug interaction potentiation, drug metabolism, poor, cyp2c19-related, drug metabolism, poor, cyp2d6-related, poor metabolizer due to cytochrome p450 cyp2c19 variant, poor metabolizer due to cytochrome p450 cyp2c9 variant, poor metabolizer due to cytochrome p450 cyp2d6 variant